World Parkinson's Day Announcement.
Our Global Linked Clinical Trials Programme:

10 trials in five years, 10 ways to potentially slow, stop and ultimately reverse Parkinson’s rapidly!

On World Parkinson's Day (11th April), The Cure Parkinson’s Trust (CPT) is delighted to announce its collaboration with the Garvan Institute, Shake It Up Australia and Parkinson’s Australia to explore running Parkinson's clinical trials in Australia.

Since the creation of the Linked Clinical Trials Programme in 2012, CPT is proud to report that six clinical trials are now underway, another trial has just finished with results due later this year, and we have three further trials imminent. Even more exciting is the speed at which these prospective treatments could be made available to people with Parkinson’s as they are all already approved in other conditions.

The charity is exploring every route in its efforts to identify treatments to change the course of Parkinson’s progression for the 10 million people living with the condition worldwide. As part of the LCT programme, this April CPT is collaborating with the Garvan Institute, Shake It Up Australia, Parkinson’s Australia to explore running further Parkinson's clinical trials in Australia.

** Please make a donation to our Linked Clinical Trials Appeal today **

                                                                                                                                                                                                                                                                                                                                                                                                                                       

Statement: Garvan Institute marks 200th anniversary of Parkinson’s disease

11 April, 2017: Today, World Parkinson’s Day marks 200 years since the disease was first identified by Dr James Parkinson.

Despite ongoing research efforts, it is still not known what causes Parkinson’s and there is no cure for the 80,000 Australians affected by the disease. While there are treatments available, they only address the symptoms, not the progression of the disease.

Garvan, along with national and international leaders in Parkinson’s research and neurologists and patients, is committed to making a difference for those with Parkinson’s and their families. In the lead up to World Parkinson’s Day, Garvan hosted a collaborative two-day meeting with representatives from The Cure Parkinson’s Trust in the UK, Shake It Up Foundation Australia (partner of The Michael J Fox Foundation for Parkinson’s Research), and Parkinson’s Australia, people living with Parkinson’s and leading researchers and neurologists. Participants discussed a number of aspects relating to Parkinson’s disease research around the globe, including an initiative to conduct clinical trials in Australia.

Today, Garvan is holding a free public seminar about Parkinson’s disease and much-needed research into this debilitating disease.

The seminar will feature Associate Professor Antony Cooper, Head of Garvan’s Neuroscience Division, as well as Dr Richard Wyse, Director of Research and Development at The Cure Parkinson’s Trust in the UK; Professor Michael Schwarzschild, Attending Neurologist at Massachusetts General Hospital in the US, and Mr Clyde Campbell, Founder and Chair of Shake It Up Australia Foundation.

Associate Professor Cooper will detail Garvan’s Parkinson’s research during the seminar, saying: “Our Parkinson’s disease research focuses on translating scientific discoveries into the clinic. We are coming at this disease from a number of angles – from trying to define characteristics of the disease, and using this information to develop biomarkers for use in clinical trials or to diagnose the disease earlier; to discovering ways to prevent the disease from progressing.”

Dr Richard Wyse, The Cure Parkinson’s Trust’s Director of Research and Development created the Linked Clinical Trials Programme; an international initiative which identifies existing therapeutic options from other diseases that have the potential to change the course of Parkinson’s, and accelerates their advance into patient clinical trials. During Garvan’s seminar he will address the importance of developing clinical trials of potentially disease modifying treatments.

“The success of The Cure Parkinson’s Trust’s Linked Clinical Trials programme is founded on three basic principles. Firstly, it accelerates prospective new Parkinson’s treatments into the clinic where people with Parkinson’s urgently need therapies which slow, stop or reverse Parkinson’s. Secondly, the initiative provides a platform through which a culture of global partnership and collaboration can be generated. Finally, we have assembled the best Parkinson’s scientists from around the world to prioritise identifying which compounds offer the most exciting opportunities to improve the lives of those people who live with this condition,” said Dr Wyse.

Professor Schwarzschild will highlight progress toward improved treatment of Parkinson’s disease and Mr Campbell will share his experiences from diagnosis to making a difference in Parkinson’s research through Shake It Up Australia Foundation.

Ends

Notes:

About the Garvan Institute: Garvan Institute of Medical Research is a world leading biomedical research institute in Sydney, pioneering study into some of the most widespread diseases of today. It aims to understand the genetic, molecular and cellular processes of health and disease as a basis for developing future cures. www.garvan.org.au

About Shake It Up Australia Foundation: Shake It Up Australia Foundation has one aim: to find a cure for Parkinson’s. Our purpose is to fund research that advances treatments for Parkinson’s’ on the path to a cure. www.shakeitup.org.au